| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/21/2006 | CA2598452A1 Treating anemia by inhibition of vegf |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701933A1 Novel compounds |
| 09/20/2006 | EP1701740A1 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 09/20/2006 | EP1397148B1 Chromium/biotin treatment of dyslipidemia |
| 09/20/2006 | EP1368364B1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/20/2006 | EP0975361B1 Methods of modulating immune coagulation |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835948A 2-acylaminothiazole derivative or its salt |
| 09/20/2006 | CN1834238A Prepn. process of and use of thrombus dissolving enzyme |
| 09/20/2006 | CN1834108A Acanthopanax giraldii Harms compound polysaccharide, prepn. technique, uses and its compound polysaccharide compsns. |
| 09/20/2006 | CN1833714A Hematopoietic pill medicinal preparation made from human placenta and pilose antler |
| 09/20/2006 | CN1833699A Quickly-acting antithrombotic and hemostatic medicine |
| 09/20/2006 | CN1833682A Chinese medicinal compsns. for treating postpartum disease |
| 09/20/2006 | CN1833676A Danlan pain relieving oral preparation |
| 09/20/2006 | CN1833646A Active substance of oxidized low density lipoprotein derivative for treating arterial thrombus form |
| 09/20/2006 | CN1833634A Fast styptic patch |
| 09/20/2006 | CN1275981C Method of monomerizing human serum albumin polymers |
| 09/20/2006 | CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275600C Vitamin-medicine composition and its use |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109332 2,4-dioxo-3-quinazolinylaryl sulfonylureas |
| 09/19/2006 | US7109331 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 09/19/2006 | US7109245 Vasoconstrictor cannabinoid analogs |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109200 Carbamate derivatives, process for producing the same and use thereof |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109191 for inhibiting bone resorption, restenosis, atherosclerosis, inflammatory arthritis, diabetic retinopathy, macular degeneration, angiogenesis, cancer |
| 09/19/2006 | US7109184 Phosphate transport inhibitors |
| 09/19/2006 | US7109180 Stimulate mammalian coronary vasodilatation, imaging the heart |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109163 For use in hemostatic devices that are suitable for applying a flowable hemostatic formulation to a site requiring hemostasis |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006096073A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors |
| 09/14/2006 | WO2006094344A1 Methods and agents for regulating cellular interactions and development |
| 09/14/2006 | WO2006061336A3 Oral compositions for absorption of phosphorus compounds |
| 09/14/2006 | US20060205951 New crystal modification of torasemide |
| 09/14/2006 | US20060205812 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 09/14/2006 | US20060205763 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205762 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205710 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205661 Novel albumin-free factor VIII formulations |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | CA2601279A1 Formulation for aviptadil |
| 09/14/2006 | CA2600460A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | CA2599872A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | CA2596830A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1699806A1 Glycosaminoglycan (gag) mimetics |
| 09/13/2006 | EP1699457A1 Novel use of ion channel active compound, meperidine, to mediate process of accelerated wound healing |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1335918B1 Novel compounds |
| 09/13/2006 | EP1331977A4 Blood centrifuge cup having a replaceable compartment for filter support |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
| 09/13/2006 | CN1832948A 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1830981A Emulsum injection for treating cerebrovascular diseases, and its prepn. art |
| 09/13/2006 | CN1830476A Nanometer dragon's blood capsule and its preparation method |
| 09/13/2006 | CN1830461A Safflower injection and its preparation method |
| 09/13/2006 | CN1830438A Preparation method of vitamin C freeze dried powder injection |
| 09/13/2006 | CN1830434A Preparation method of troxerutin injection |
| 09/13/2006 | CN1830427A Preparation method of sodium ferulate freeze dried powder injection |
| 09/13/2006 | CN1830423A Preparation method of garlicin injection |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274345C Oral liquid for abnormal metrorrhagia |
| 09/13/2006 | CN1274338C Traditional Chinese medicine for treating aplastic anemia and its preparation process |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |